Inncelerex Information

Inncelerex provides expertise in:Modeling and SimulationClinical PharmacologyPharmacologyPre-clinical developmentIND enabling activitiesThe range of expertise listed above would enable pharmaceutical companies to have an integrated approach in search for signals of drug efficacy and safety at the early stages of development. This would in turn enable early Go/No Go decisions that lead to the selection of more promising projects and drug candidates and also lead to the discontinuation of less viable drug candidates, both of which would translate to an increase in cost-efficiency. Through affiliate companies, Inncelerex is also involved in IP development, IP acquisition, and R&D of:Innovative drug delivery platformsDrug candidates for metabolic diseasesDrug candidates for CNS indications